NFE2L2 and breast carcinoma: Nrf2 overexpression can induce the activation of glucose-6-phosphate dehydrogenase (G6PD)/HIF-1α signaling, consequently conferring the proliferation and metastasis of breast cancer cells via EMT signaling (epithelial–mesenchymal transition) due to extensive NADPH levels [144].